Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-14-032369)

Filing Details

Accession Number:: 0001209191-14-032369
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-05-08 17:57:48
Reporting Period:: 2014-05-07

Filing Date:: 2014-05-08
Accepted Time:: 2014-05-08 17:57:48
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1341235	Aldeyra Therapeutics Inc.	ALDX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1300858	Joseph Martin Joyce	C/O Aldeyra Therapeutics, Inc. 15 New England Executive Park Burlington MA 01803		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-05-07	12,500	$8.00	12,500	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Acquisiton	2014-05-07	12,166	$0.00	12,166	$8.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
12,166		2024-05-06	No	4	A	Direct

Footnotes

Exercisable in equal annual installments over three years of continuous service after May 7, 2014.